Amplifying blood biomarkers with ultrasound to help predict the aggressiveness of prostate cancer 

Presenter: Dr. Roger Zemp
Original Date: Tuesday, May 31, 2016

Join Dr. Roger Zemp to learn about how:
  • Blood biomarkers are used in the detection of prostate cancer but may also offer promise in determining how aggressive a prostate cancer is
  • Current biomarker testing cannot yet predict aggressiveness, in part due to the low levels of informative prostate biomarkers in the blood
  • We are developing technologies that may help (1) amplify the level of such informative biomarkers in the blood using ultrasound and (2) enrich such biomarkers using magnetic trapping and nanoparticles

Dr. Roger Zemp's Biography:

Roger Zemp is an Associate Professor of Electrical and Computer Engineering and Biomedical Engineering at the University of Alberta. He earned his BSc in Physics at the University of Alberta in 1998, his MASc from the Institute of Biomaterials and Biomedical Engineering at the University of Toronto in 2000 and his PhD in Biomedical Engineering from the University of California, Davis in 2004. He worked as a postdoctoral fellow with Prof. Lihong Wang at Texas A&M University in Biomedical Optics from 2004-2006 then continued with Prof. Wang in Washington University in St. Louis from 2006-2007. He has been a faculty member at the University of Alberta since 2007. He is the author of 68 journal publications and over 140 conference publications or abstracts. He is on the editorial board of a number of journals and directs a research program with interests in biomedical optics, biomedical ultrasonics, photoacoutsic imaging, and micro- and nano-technologies for biomedicine. 

Expert AngleAbout Expert Angle

Expert Angle is designed to expand our reach and address the many varied and complex questions that come with a prostate cancer diagnosis. These webinars will address topics important to men with prostate cancer along different points of the cancer care continuum and those within their circle of care as well as the general public and representatives from the clinical community.
The meetings are hosted using interactive on-line technology and feature leading experts in prostate cancer - making them accessible to anyone, regardless of their location, within Canada. The platform allows PCC to communicate directly with individuals in a variety of settings (i.e. in their homes, support group meetings, community centres) and geographic locations (i.e. urban, rural and remote locations) as well as measure engagement.   

View more Expert Angle webinars.


Prostate Cancer Awareness Month

Donate Now!

Subscribe to our free monthly e-newsletter!

* indicates required


PCC Spotlight
Prostate Cancer Canada launches first national program in radionuclide therapy

Toronto, June 27, 2018 – Canadian researchers are leading the future of treatment for men with advanced prostate cancer in this country, with a new Prostate Cancer Canada grant funded by the Movember Foundation.

Honouring dad this Father’s Day the Canadian way: In plaid

TORONTO, ON – (May 8, 2018) – Plaid replaces business-casual on Friday, June 15 as hundreds of thousands of Canadians don the iconic Canadian attire all to honour dad and end prostate cancer.

The Finger – A tried and true method to save lives

TORONTO, CANADA (May 8, 2018) – Every day, more and more methods to detect prostate cancer are being explored, but the tried and true methods of a digital rectal examination (DRE) – where a healthcare professional inserts a gloved finger into the rectum to check for abnormalities, paired with a blood test known as the prostate-specific antigen (PSA) test – which you can get through your family doctor, are still the long-standing proven ways to save a life.

Click here for news archive